The absorption of subcutaneously injected insulin was examined by injecting semisynthetic [3H] insulin in anaesthetized pigs and subsequently analysing the tissue excised from the injection site. Contrary to previously accepted views, a significant proportion of insulin was degraded at the injection site. The disappearance of intact [3H] insulin from the injection site followed a monoexponential function with a half-time of 59 min.
In previous attempts to assess the absorption of insulin from its subcutaneous depot in man, radioiodinated insulin preparations were injected, and the disappearance of the radioactivity from the injection site measured by an external gamma-counter [1-61. Among other assumptions, this method depends on there being only negligible local degradation of the injected insulin. When well characterized preparations of highly purified [125I] Actrapid| were used, it was found that the time course of disappearance of 125I from the injection site was linear, at least up to 4 hours [5, 6] ; on injection of [125I] Actrapid | Insulin in the leg, mobilization of the first 50% of the radioactivity took between 160 and 180 min [5, 6] . Thus, if these findings are correct, at a time when Actrapid| reaches its maximal hypoglycaemic [7, 8] , only about I/5 to 1/4 of the injected material has been absorbed from the subcutaneous depot. This apparent discrepancy prompted us to reinvestigate the absorption kinetics of SC injected insulin in anaesthetized pigs using a direct method.
Me~ods
Semisynthetic [3HI insulin was used; the authenticity of this as a tracer has been discussed elsewhere [9] [10] [11] [12] . The [3H] insulin was injected SC in anaesthetized pigs and the site of injection excised at intervals thereafter. The excised tissue was subjected to analysis for [3H] insulin and its degradation products.
One batch of semisynthetic [3H] insulin (pork) was prepared and purified according to Halban and Offord [9, 10] and used for all the studies. On the day of the experiment, [3HI insulin was repurified by sephadex G 50 column chromatography as described previously [10] . By this method more than 95% of the radioactivity in the purified [3H] insulin is immunoprecipitable [9] [10] [11] [12] ; the biological activity of the purified [3H] insulin (on blood glucose depression in rats) is indistinguishable from native insulin. In the following experiments the specific radioactivity of the labelled insulin was 11 Ci/mmol and 96 __+_ 1% (Mean _+ SEM, n = 4) of the 3H was associated with intact [3H] insulin. An amount (0.9-1.4
• 105 dpm) of this material, equivalent to 0.5-0.8 mU insulin, was prepared for injection in 0.2-0.3 ml of 0.2 mol/l glycine-HCl-buffer, pH 7.4 containing 2.5 g/1 bovine serum albumin (BSA). In some experiments, 10 units of crystalline pork insulin was included in the injected solution. In all cases, Dextran Blue | (Pharmacia) was added to the solution (20 g/l) to facilitate location of the injected material during excision of the site. Preliminary experiments had shown that dispersion of the injected material in the subcutaneous adipose tissue was quite variable.
The mixtures were injected subcutaneously at several sites in the abdominal and the gluteal regions of overnight-fasted pigs (weight 123 _+ 14kg, n = 6) anaesthetized with Methonidate Hydrochloride, 8 mg/kg, following premedication with Atropin 0.02 mg/kg and Sresnil 2 mg/kg. The sites were approximately 12 cm apart. At set times between 15 and 160 rain, 3 to 5 g subcutaneous tissue around the injection site was excised en bloc and divided into portions of approximately i g according to the distribution of the dye: two portions were intensely coloured, one slightly coloured, and a fourth portion uncoloured. No blue material was left in the animal. The tissue pieces were immediately sohibilized in 2 g/100ml sodium-dodecylsulphate (SDS) and aliquots of the extracts were subjected to routine counting procedures in a liquid scintillation counter using Instagel a as the scintillant. The minimum radioactivity counted per ml tissue extract was 500 cpm. Once the counts had been recorded a 3H standard was added to assess the quenching in each individual tube. Most (94 _+ 1%) of the extractable 3H was localized in the coloured biopsy portions. Aliquots of these soluble extracts were assayed for 0012-186X/79/0017/0097/$01.00 
Results
The disappearance of total radioactivity of [3I-I] insulin (Table 1) is described by the mono-exponential function y' = 92 • e -~176 where y' is the radioactivity recovered by biopsy of the injection site expressed as a percentage of the amount of 3H which had been injected, and t is the time interval in minutes after the injection. Thus, assuming mono-exponential decay (Table 1) . Since the extent of degradation was independent of the time interval after the injection, approximately 1/5 of the administered insulin will have been degraded within the first 15min following the injection. Highmolecular-weight degradation products tended to increase and the low-molecular-weight fraction to decrease with time; these changes did, however, not reach statistical significance. Nevertheless, degradation products of low molecular weight might be cleared from the site more rapidly than intact insulin: our estimate of the extent of degradation at any time is based only on material that remains at the site and should therefore be regarded as a minimum value.
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If the intact [3H] insulin recovered from the injection site (total 3H corrected for tritiated degradation products, table 1) expressed as percent of the dose of intact [3HI insulin injected at zero time (total injected dose of 3H corrected for the initial impurity of 4 _+ 1%) is plotted against the time, the disappearance of intact [3H] insulin from the injection site can be calculated (Figure 1 ). This is also a monoexponential function, y = 76 • e -0.m2 t (p < 0.001). The addition of 10 U unlabelled pork insulin to the injected solution, examined at four different time points (Figure 1) , did not alter the rate of disappearance of [3HI insulin from the subcutaneous injection site. Thus, 50% of the injected insulin had disappeared from the injection site at 35 min, due both to local degradation and to mobilization.
Discussion
In contrast to previous attempts to measure the absorption of subcutaneously injected insulin by indirect methods [1] [2] [3] [4] [5] [6] , this study reveals a mono-exponential time curve for the disappearance of insulin from its subcutaneous injection site in pigs; the first 50% of the insulin dose administered disappeared from the injection site after 35 min. Such a time course of insulin disappearance albeit derived from anaesthetized pigs -corresponds well with the kinetics of the appearance of 3H insulin in the blood after SC injection of the tracer in diabetic patients [13] , and with the time course of the hypoglycaemic effect after SC insulin injections of short-acting soluble insulin [7, 8] .
The significant degradation of insulin at the subcutaneous injection site shown in this study is in accordance with the demonstration of a specific insulin-degrading enzyme in adipose tissue [14] . We have recently shown approximately 50% degradation of [3HI insulin over one hour when 0.5 mU of insulin was incubated at 37 ~ C with 1 g of rat adipose tissue in 1.5 ml Krebs-Ringer-Bicarbonate buffer containing albumin. This degradation decreased to 10% when 1 U of pork insulin was added to the incubation mixture. In preliminary studies, degradation was also observed when [3H] insulin was injected into an isolated piece of pig subcutaneous tissue incubated at 37 ~ C.
The demonstration that subcutaneously injected insulin is locally degraded is of particular clinical interest since it may explain the increased hypoglycaemic effect of IV insulin compared to equivalent doses given SC in diabetic man [15] [16] [17] and animals [18] . If such degradation also occurs in man, it may differ considerably between different injection sites and from one patient to another. This may be a cause for otherwise unexplained variations in insulin requirements among juvenile type diabetics. 
